Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphoma

To distinguish prognostic subgroups patients with aggressive B cell lymphoma, we analyzed 800 MIRNAS’s expression with Nanostring NCounter Micna Mirna Test on cohort 228 FFPE samples of patients registered in the Ricover-60 trial and megachoep. We identify significant Mirna signatures for the overall survival (OS) (OS) and progressive free survival (PFS) with linear cox regression punished by Laso. The level of high expression of the MIR-130A-3P and MIR-423-5P shows a better prognosis, while the high level of MIR-374B-5P, MIR-590-5P, MIR-186-5P, and MIR-106B-5P-5P increases Patients’ risk level for OS.

Regarding the PFS high expression MIR-365A-5P In addition to two other MIRNAS increases the prognosis and high level of MIR374A-5P, MIR-106B-5P, and MIR-590-5P, connected with an increased risk and poor prognosis. We identified the signature of Mirna to divide patients into two different risk groups. This prognostic model can be used in risk stratification in clinical trials in the future and helps make personalized therapeutic decisions.

Comparative analysis of transcript profile, proteome, and mirna cupffer cells and monocytes

The macrophage population in most mammalian organs consists of different origin cells. The macrophage of the population comes from the erythromiseloid precursor of the wall of the egg yolk bag; Maintenance of the amount of macrophages in the postnatal ontogenesis is practically independent of the hematopoiesis bone marrow. The largest population of the population of embryonic population is found in the central nervous system (Mikroglia) and the liver (Cell Cupffer). Conversely, dermis and mucous membranes become largely colonized by monocytes of bone marrow derivatives which show clear and phenotical plasticity.

In this study, we compare cupffer cells and monocytes using immunofenotype, gene expression profiles, proteome, and microrna collections. The observed difference does not consider the macrophage of the residents’ hearts as pure m2 macrophages or the situation owned by a monocyte has a pure M1 feature. Monocytes show signs of high plasticity and sensitivity to the pattern of molecules related to pathogens (for example, high transcription rates for <i> TLR 2 </ i>, <i> 4 </ i>, <i> 7 </ i>, and <i> 8 </ i>). Conversely, the macrophage of the Heart of the population is clearly involved in the regulations of certain organ functions (nitrogen metabolism, a complementary system protein synthesis).

PMDNE: Prediction of the Mirna-Disease Association based on network embedding and network similarity analysis

Prediction of success from the Mirna-Disease Association is nontrivial for the diagnosis and prognosis of genetic diseases. There are many methods for predicting mirna and disease, but many biological data and complex, and they are often in network form. Ways to accurately use MIRNA features and biological tissue related to diseases to predict unknown associations always become a challenge. Here, we propose PMDNE, a method based on network embedding and network similarity analysis, to predict Mirna’s associations.

At PMDNE, the structure of bipartite graphics network is improved, and the generator runs randomly designed. For embedded vectors, 128 dimensions are used, and predictive accuracy increases significantly. Compared to other network embedding methods, PMDNE is comparable and competitive with the method of art conditions. The method we can solve features extraction features, reduce the dimensions of features, and increase the efficiency of predictions of mirna-disease associations. This method can also be extended to other areas for biomedical tissue predictions.

Effect of lifestyle factors on mirna expression and signal paths: reviews

The term ‘lifestyle’ includes various factors that contribute to maintenance of good health status. Increased evidence shows that lifestyle factors can affect epigenetic mechanisms, such as MIRNAS’s expression. MIRNA dysregulation can modify gene expression and molecular pathways that can cause functional changes. This review summarizes human studies that highlights that diet, physical activity, smoking consumption and alcohol can affect the Mirna engine and some biological functions.

Most Mirnas are involved in molecular lines that affect inflammation, cell cycle regulations and carcinogenesis produce onset or the development of pathological conditions. Investigating this interaction will be very important to understand the etiology of the pathological process, the potential for new care strategies and to prevent disease.

From the Mirna target network to the Mirna function: MIR-375 can regulate apoptosis and dynamics of actin in the heart muscle through the path that depends on RHO-GTPASES

Micrornas (MIRNAS) is a short ribonucleic acid molecule (RNA), without code, which is involved in the main biological process regulations, such as apoptosis or proliferation and cell differentiation, through specific interactions of sequences with the MRNAS target. In this study, we propose workflows to predict the MIRNA function by analyzing their target gene network structure. This workflow is applied to study the functional role of the MIR-375 in the heart of the muscle (myocardium), because Mirna previously proved to be associated with heart disease, and the data on its functions in myocardium was largely unclear.

Hygromycin B

AT190 1mg
EUR 1336.8

Hygromycin B

H007-1G 1 g
EUR 120

Hygromycin B

H007-500MG 500 mg
EUR 81.6

Hygromycin B

H007-5x1G 5 x 1 g
EUR 384

Hygromycin B

HY-B0490 10mM/1mL
EUR 151.2

Hygromycin B

GA7834-100MG 100 mg
EUR 74.4

Hygromycin B

GA7834-1G 1 g
EUR 151.2

Hygromycin B

GA7834-500MG 500 mg
EUR 103.2

Hygromycin B

GA7834-5G 5 g
EUR 495.6

Hygromycin B

2589-1000 each
EUR 314.4

Hygromycin B

2589-500 each
EUR 235.2

HYGROMYCIN B SOLUTION

30-240-CR 20 mL/pk
EUR 188.4
Description: Media Catalog; Cell Culture Reagents

Hygromycin B [BSA]

DAG4469 0.5mg
EUR 936

Hygromycin B [KLH]

DAG4485 0.5mg
EUR 1248

Hygromycin B Concentrated

H001-1MU 1 MU
EUR 116.4

EZSolution? Hygromycin B

2590-20 each
EUR 326.4

Hygromycin B, 10g

R3128-10g each
EUR 2724

Hygromycin B, 1g

R3128-1g each
EUR 362.4

Hygromycin B EvoPure®

H010-1G 1 g
EUR 225.6

Hygromycin B EvoPure®

H010-500MG 500 mg
EUR 172.8

Hygromycin B EvoPure (Low Endotoxin)

H024-1G 1g
EUR 650.4

Hygromycin B EvoPure (Low Endotoxin)

H024-500MG 500 mg
EUR 415.2

Hygromycin B Solution (Low Endotoxin)

H026-20ML 20 mL
EUR 142.8

Hygromycin Antibody

abx023698-1mg 1 mg
EUR 1312.8

Hygromycin Antibody

abx023699-1mg 1 mg
EUR 1312.8

Escherichia coli Hygromycin-B 4-O-kinase (hph)

1-CSB-EP365448ENL
  • EUR 733.20
  • EUR 370.80
  • EUR 2192.40
  • EUR 1126.80
  • EUR 1461.60
  • EUR 476.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Escherichia coli Hygromycin-B 4-O-kinase(hph) expressed in E.coli

Escherichia coli Hygromycin-B 4-O-kinase (hph)

1-CSB-EP365448ENLa0
  • EUR 733.20
  • EUR 370.80
  • EUR 2192.40
  • EUR 1126.80
  • EUR 1461.60
  • EUR 476.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Escherichia coli Hygromycin-B 4-O-kinase(hph) expressed in E.coli

Escherichia coli Hygromycin-B 4-O-kinase (hph)

1-CSB-YP365448ENL
  • EUR 814.80
  • EUR 402.00
  • EUR 2606.40
  • EUR 1261.20
  • EUR 1730.40
  • EUR 522.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Escherichia coli Hygromycin-B 4-O-kinase(hph) expressed in Yeast

Hygromycin phosphotransferase antibody

10-1418 1 mg
EUR 813.6
Description: Mouse monoclonal Hygromycin phosphotransferase antibody

Hygromycin phosphotransferase antibody

10-1419 1 mg
EUR 813.6
Description: Mouse monoclonal Hygromycin phosphotransferase antibody

Hygromycin phosphotransferase antibody

10-1420 1 mg
EUR 813.6
Description: Mouse monoclonal Hygromycin phosphotransferase antibody

Hygromycin phosphotransferase antibody

10-1421 1 mg
EUR 813.6
Description: Mouse monoclonal Hygromycin phosphotransferase antibody

Hygromycin B Solution (50 mg/ml in PBS Buffer)

H011-20ML 20 mL
EUR 133.2

Hygromycin B Solution (50 mg/ml in PBS Buffer)

H011-5x20ML 5x20mL
EUR 440.4

Hygromycin B EvoPure Solution (100 mg/ml in PBS Buffer)

H015-10x2ML 10 x 2 mL
EUR 340.8

Hygromycin B EvoPure Solution (100 mg/ml in PBS Buffer)

H015-5x2ML 5 x 2 mL
EUR 225.6

Cas9 Lentivirus (Hygromycin Selection)

78067 500 µl x 2
EUR 795
Description: Cas9 Lentivirus can be used to generate Cas9 expressing cells in almost any mammalian cell line. Cells stably expressing Cas9 can then be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines.

The Cas9 Lentiviruses are replication incompetent, HIV-based VSV-G pseudo-typed lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a Cas9 gene driven by an EF1a promoter, along with a Hygromycin selection marker._x000D_

Enhanced GFP Lentivirus (Hygromycin)

78639-H 500 µl x 2
EUR 835
Description: Enhanced green fluorescent protein (eGFP) is a modified (F64L and S65T mutations) version of the native GFP protein isolated from jellyfish (Aequorea victoria), with increased fluorescence and more efficient folding. The Enhanced GFP Lentivirus are replication-incompetent, HIV based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express eGFP under a CMV promoter. eGFP expression and transduction efficiency can easily be verified and optimized via fluorescence microscopy or flow cytometry. eGFP has an excitation wavelength of 488 nm, an emission wavelength of 509 nm, and extinction coefficient of 55,000 M-1cm-1.

Firefly Luciferase Lentivirus Hygromycin

79692-H 500 µl x 2
EUR 875
Description: The Firefly Luciferase Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. These viruses constitutively express firefly luciferase under a CMV promoter.

Fmoc-b,b-diphenyl-Ala-OH

B-2725.0250 250.0mg
EUR 166.8
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6]

Fmoc-b,b-diphenyl-Ala-OH

B-2725.1000 1.0g
EUR 428.4
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6]

Fmoc-b,b-diphenyl-Ala-OH

B-2725.5000 5.0g
EUR 1603.2
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6]

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-100ug

QP7397-ye-100ug 100ug
EUR 945.6

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-10ug

QP7397-ye-10ug 10ug
EUR 434.4

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-1mg

QP7397-ye-1mg 1mg
EUR 3296.4

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-200ug

QP7397-ye-200ug 200ug
EUR 1512

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-500ug

QP7397-ye-500ug 500ug
EUR 2164.8

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His, Yeast-50ug

QP7397-ye-50ug 50ug
EUR 576

Phenolics Mix B

8040-B 1ML
EUR 61.56

Analyte Mix B

507-B 1ML
EUR 182.4

Analyte Mix B

5081-B 1ML
EUR 129.96

MEF Feeder Cells (Hygromycin-resistant)

CBA-313 1 vial
EUR 553.2
Description: MEF Feeder Cells are mouse embryonic fibroblasts that allow stem cell culture without LIF. Cells must be mitotically inactivated prior to addition of stem cells. Hygromycin resistant.

Expression Negative Control Lentivirus (Hygromycin)

79902-H 500 µl x 2
EUR 795
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-100ug

QP7397-ec-100ug 100ug
EUR 848.4

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-10ug

QP7397-ec-10ug 10ug
EUR 391.2

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-1mg

QP7397-ec-1mg 1mg
EUR 2763.6

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-200ug

QP7397-ec-200ug 200ug
EUR 1338

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-500ug

QP7397-ec-500ug 500ug
EUR 1816.8

Recombinant E.coli Hygromycin-B 4-O-kinase Protein, His-SUMO, E.coli-50ug

QP7397-ec-50ug 50ug
EUR 522

Fmoc-b-Ala-OPfp

B-1765.0005 5.0g
EUR 283.2
Description: Sum Formula: C24H16F5NO4; CAS# [149303-38-8]

Fmoc-b-Ala-OPfp

B-1765.0025 25.0g
EUR 1009.2
Description: Sum Formula: C24H16F5NO4; CAS# [149303-38-8]

Fmoc-b-Ala-OH

B-1025.0005 5.0g
EUR 138
Description: Sum Formula: C18H17NO4; CAS# [35737-10-1]

Fmoc-b-Ala-OH

B-1025.0025 25.0g
EUR 283.2
Description: Sum Formula: C18H17NO4; CAS# [35737-10-1]

Fmoc-b-Ala-OH

B-1025.0100 100.0g
EUR 762
Description: Sum Formula: C18H17NO4; CAS# [35737-10-1]

Purgeable Gases Mix B

624-B 1ML
EUR 249.66

Purgeable Gases Mix B

5022-B 1ML
EUR 27.36

Fmoc-b-cyclohexyl-Ala-OH

B-1975.0001 1.0g
EUR 151.2
Description: Sum Formula: C24H27NO4; CAS# [135673-97-1]

Fmoc-b-cyclohexyl-Ala-OH

B-1975.0005 5.0g
EUR 501.6
Description: Sum Formula: C24H27NO4; CAS# [135673-97-1]

Fmoc-b-cyclohexyl-Ala-OH

B-1975.0025 25.0g
EUR 1430.4
Description: Sum Formula: C24H27NO4; CAS# [135673-97-1]

Fmoc-b-cyclopropyl-Ala-OH

B-2905.0001 1.0g
EUR 414
Description: Sum Formula: C21H21NO4; CAS# [214750-76-2]

Fmoc-b-cyclopropyl-Ala-OH

B-2905.0005 5.0g
EUR 1561.2
Description: Sum Formula: C21H21NO4; CAS# [214750-76-2]

Polynuclear Aromatic Hydrocarbons Mix B

8100-B 1ML
EUR 788.88

TCR Activator Lentivirus (EF1a Promoter/Hygromycin)

79894-EH 500 µl x 2
EUR 795
Description: The TCR Activator Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a gene for a membrane-bound, engineered T cell receptor (TCR) activator driven by a CMV promoter or an EF1a promoter. After transduction, the expression of TCR activator can be monitored in the target cells.

Fmoc-b-(2-thienyl)-Ala-OH

B-1665.0001 1.0g
EUR 340.8
Description: Sum Formula: C22H19NO4S; CAS# [130309-35-2]

Fmoc-b-(2-thienyl)-Ala-OH

B-1665.0005 5.0g
EUR 1255.2
Description: Sum Formula: C22H19NO4S; CAS# [130309-35-2]

Fmoc-b-(3-pyridyl)-Ala-OH

B-2005.0001 1.0g
EUR 471.6
Description: Sum Formula: C23H20N2O4; CAS# [175453-07-3]

Fmoc-b-(3-pyridyl)-Ala-OH

B-2005.0005 5.0g
EUR 1778.4
Description: Sum Formula: C23H20N2O4; CAS# [175453-07-3]

Fmoc-b-cyclohexyl-D-Ala-OH

B-2345.0001 1.0g
EUR 181.2
Description: Sum Formula: C24H27NO4; CAS# [144701-25-7]

Fmoc-b-cyclohexyl-D-Ala-OH

B-2345.0005 5.0g
EUR 618
Description: Sum Formula: C24H27NO4; CAS# [144701-25-7]

Fmoc-b-cyclohexyl-D-Ala-OH

B-2345.0025 25.0g
EUR 2358
Description: Sum Formula: C24H27NO4; CAS# [144701-25-7]

Fmoc-b-(3-benzothienyl)-Ala-OH

B-2830.0001 1.0g
EUR 254.4
Description: Sum Formula: C26H21NO4S; CAS# [177966-60-8]

Fmoc-b-(3-benzothienyl)-Ala-OH

B-2830.0005 5.0g
EUR 907.2
Description: Sum Formula: C26H21NO4S; CAS# [177966-60-8]

Fmoc-b-cyclopropyl-D-Ala-OH

B-2915.0001 1.0g
EUR 704.4
Description: Sum Formula: C21H21NO4; CAS# [170642-29-2]

Fmoc-b-cyclopropyl-D-Ala-OH

B-2915.0005 5.0g
EUR 2706
Description: Sum Formula: C21H21NO4; CAS# [170642-29-2]

Fmoc-b-(2-quinolyl)-Ala-OH

B-3165.0250 250.0mg
EUR 457.2
Description: Sum Formula: C27H22N2O4; CAS# [214852-56-9]

Fmoc-b-(2-quinolyl)-Ala-OH

B-3165.1000 1.0g
EUR 1284
Description: Sum Formula: C27H22N2O4; CAS# [214852-56-9]

Fmoc-b-azido-Aib-OH · BHA

B-4530.0001 1.0g
EUR 846
Description: Sum Formula: C19H18N4O4·C13H13N; CAS# [1926163-90-7] net

Fmoc-b-(3-pyridyl)-D-Ala-OH

B-2040.0001 1.0g
EUR 327.6
Description: Sum Formula: C23H20N2O4; CAS# [142994-45-4]

Fmoc-b-(3-pyridyl)-D-Ala-OH

B-2040.0005 5.0g
EUR 1197.6
Description: Sum Formula: C23H20N2O4; CAS# [142994-45-4]

Fmoc-b-(2-thienyl)-D-Ala-OH

B-2120.0001 1.0g
EUR 370.8
Description: Sum Formula: C22H19NO4S; CAS# [201532-42-5]

Fmoc-b-(2-thienyl)-D-Ala-OH

B-2120.0005 5.0g
EUR 1371.6
Description: Sum Formula: C22H19NO4S; CAS# [201532-42-5]

Fmoc-b-(2-quinolyl)-D-Ala-OH

B-3170.0250 250.0mg
EUR 529.2
Description: Sum Formula: C27H22N2O4; CAS# [214852-58-1]

Fmoc-b-(2-quinolyl)-D-Ala-OH

B-3170.1000 1.0g
EUR 1531.2
Description: Sum Formula: C27H22N2O4; CAS# [214852-58-1]

Fmoc-b-(3-benzothienyl)-D-Ala-OH

B-3435.0001 1.0g
EUR 400.8
Description: Sum Formula: C26H21NO4S; CAS# [177966-61-9]

Fmoc-b-(3-benzothienyl)-D-Ala-OH

B-3435.0005 5.0g
EUR 1488
Description: Sum Formula: C26H21NO4S; CAS# [177966-61-9]

Fmoc-b-(1-piperazinyl)-Ala(Boc)-OH

B-3725.0250 250.0mg
EUR 459.6
Description: Sum Formula: C27H33N3O6; CAS# [313052-20-9]

Fmoc-b-(1-piperazinyl)-Ala(Boc)-OH

B-3725.1000 1.0g
EUR 1305.6
Description: Sum Formula: C27H33N3O6; CAS# [313052-20-9]

Fmoc-b-azido-D-Aib-OH · BHA

B-4535.0001 1.0g
EUR 846
Description: Sum Formula: C19H18N4O4·C13H13N; CAS# [1926163-91-8] net

Fmoc-Asn(GlcNAc(Ac)3-b-D)-OH

B-2480.0100 100.0mg
EUR 704.4
Description: Sum Formula: C33H37N3O13; CAS# [131287-39-3]

Fmoc-Asn(GlcNAc(Ac)3-b-D)-OH

B-2480.0250 250.0mg
EUR 1371.6
Description: Sum Formula: C33H37N3O13; CAS# [131287-39-3]

Fmoc-N-(N-b-Boc-aminoethyl)-Gly-OH

B-3285.0001 1.0g
EUR 544.8
Description: Sum Formula: C24H28N2O6; CAS# [141743-15-9]

Fmoc-N-(N-b-Boc-aminoethyl)-Gly-OH

B-3285.0005 5.0g
EUR 2037.6
Description: Sum Formula: C24H28N2O6; CAS# [141743-15-9]

Fmoc-Ser(GlcNAc(Ac)3-b-D)-OH

B-3865.0025 25.0mg
EUR 318
Description: Sum Formula: C32H36N2O13; CAS# [160067-63-0]

Fmoc-Ser(GlcNAc(Ac)3-b-D)-OH

B-3865.0100 100.0mg
EUR 882
Description: Sum Formula: C32H36N2O13; CAS# [160067-63-0]

Fmoc-Ser(GlcNAc(Ac)3-b-D)-OH

B-3865.0250 250.0mg
EUR 1725.6
Description: Sum Formula: C32H36N2O13; CAS# [160067-63-0]

Fmoc-Ser(GalNAc(Ac)3-b-D)-OH

B-4235.0025 25.0mg
EUR 318
Description: Sum Formula: C32H36N2O13; CAS# [1676104-71-4]

Fmoc-Ser(GalNAc(Ac)3-b-D)-OH

B-4235.0100 100.0mg
EUR 882
Description: Sum Formula: C32H36N2O13; CAS# [1676104-71-4]

Fmoc-Ser(GalNAc(Ac)3-b-D)-OH

B-4235.0250 250.0mg
EUR 1725.6
Description: Sum Formula: C32H36N2O13; CAS# [1676104-71-4]

Fmoc-Thr(GalNAc(Ac)3-b-D)-OH

B-4240.0025 25.0mg
EUR 332.4
Description: Sum Formula: C33H38N2O13; CAS# [133575-43-6]

Fmoc-Thr(GalNAc(Ac)3-b-D)-OH

B-4240.0100 100.0mg
EUR 924
Description: Sum Formula: C33H38N2O13; CAS# [133575-43-6]

Fmoc-Thr(GalNAc(Ac)3-b-D)-OH

B-4240.0250 250.0mg
EUR 1812
Description: Sum Formula: C33H38N2O13; CAS# [133575-43-6]

Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH

B-4245.0025 25.0mg
EUR 332.4
Description: Sum Formula: C33H38N2O13; CAS# [160168-40-1]

Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH

B-4245.0100 100.0mg
EUR 924
Description: Sum Formula: C33H38N2O13; CAS# [160168-40-1]

Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH

B-4245.0250 250.0mg
EUR 1812
Description: Sum Formula: C33H38N2O13; CAS# [160168-40-1]

EP Reagent Potassium Tetraiodomercurate Sol. Alkaline Part B

1071600-B 100ML
EUR 50.16

Hematoxylin, Weigert's Iron (Part B)

HWI-B-250 250 ml
EUR 86.4

Fmoc-b-(7-methoxy-coumarin-4-yl)-Ala-OH

B-3740.0500 500.0mg
EUR 414
Description: Sum Formula: C28H23NO7; CAS# [524698-40-6]

Fmoc-b-(7-methoxy-coumarin-4-yl)-Ala-OH

B-3740.1000 1.0g
EUR 726
Description: Sum Formula: C28H23NO7; CAS# [524698-40-6]

Goat Anti-Protective Antigen 83 (PA83; B Anthracis) IgG-biotinylated

PA16-B 50 ug
EUR 489.6

ODN 1668 -Type B murine TLR9 Agonist biotin conjugate- Antigen grade

ODN1668-B Custom Ask for price

ODN 1826- Type B murine TLR9 Agonist Biotin conjugate, antigen grade

ODN1826-B Custom Ask for price

Fmoc-b-(2,2-dimethyl-4H-benzo[1,3]dioxin-6-yl)-Ala-OH

B-3310.0001 1.0g
EUR 618
Description: Sum Formula: C28H27NO6; CAS# [252049-13-1]

Fmoc-b-(2,2-dimethyl-4H-benzo[1,3]dioxin-6-yl)-Ala-OH

B-3310.0005 5.0g
EUR 2371.2
Description: Sum Formula: C28H27NO6; CAS# [252049-13-1]

Mouse Monoclonal Anti-Rat CD45RA/B Biotin (Clone OX-33) (mouse IgG1)

RCD045RAB-B 100 tests
EUR 562.8

metallo-b-lactamase inhibitor, DNA aptamer, Biotinylated

AD-159-B Custom Ask for price

Multivalent B-cell receptor specific, DNA apatamer, Biotinylated

AD-156-B Custom Ask for price

ODN 2006 (CpG 7909/ODN7909) -Type B-human TLR9 agonist Biotin conjugate-antigen grade

ODN2006-B 50 ug
EUR 270

ELISA PLATE WASHER : MICRO WASH 1100

1100 1 unit
EUR 2403.6

ELISA PLATE READER : MICRO READ 1000

1000 1 unit
EUR 2628

ELISA PLATE SHAKER : MICRO SHAKE 1200

1200 1 unit
EUR 916.8

Bovine Cyclophilin B (CYPB) ELISA Kit

DLR-CYPB-b-48T 48T
EUR 656.4
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Cyclophilin B (CYPB) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Bovine Cyclophilin B (CYPB) ELISA Kit

DLR-CYPB-b-96T 96T
EUR 858
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Cyclophilin B (CYPB) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Bovine Fetuin B (FETUB) ELISA Kit

DLR-FETUB-b-48T 48T
EUR 682.8
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Fetuin B (FETUB) in samples from serum, plasma or other biological fluids.

Bovine Fetuin B (FETUB) ELISA Kit

DLR-FETUB-b-96T 96T
EUR 895.2
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Fetuin B (FETUB) in samples from serum, plasma or other biological fluids.

Bovine Cyclophilin B (CYPB) ELISA Kit

RD-CYPB-b-48Tests 48 Tests
EUR 666

Bovine Cyclophilin B (CYPB) ELISA Kit

RD-CYPB-b-96Tests 96 Tests
EUR 925.2

Bovine Cyclophilin B (CYPB) ELISA Kit

RDR-CYPB-b-48Tests 48 Tests
EUR 696

Bovine Cyclophilin B (CYPB) ELISA Kit

RDR-CYPB-b-96Tests 96 Tests
EUR 968.4

Bovine Fetuin B (FETUB) ELISA Kit

RDR-FETUB-b-48Tests 48 Tests
EUR 728.4

Bovine Fetuin B (FETUB) ELISA Kit

RDR-FETUB-b-96Tests 96 Tests
EUR 1014

Bovine Fetuin B (FETUB) ELISA Kit

RD-FETUB-b-48Tests 48 Tests
EUR 696

Bovine Fetuin B (FETUB) ELISA Kit

RD-FETUB-b-96Tests 96 Tests
EUR 968.4

LEXSY Hygro, Hygromycin B, 1 ml (100 mg/ml) ** shipped on blue ice - must be shipped via overnight service

M-AB-104S 1 ml
EUR 76
Description: LEXSY Hygro, Hygromycin B, 1 ml (100 mg/ml) ** shipped on blue ice - must be shipped via overnight service

Platelet-Derived Growth Factor B-chain (36t), DNA Aptamer, Biotinylated

AD-136-B Custom Ask for price

NATtrol Influenza A/B Positive Control (6 X 0.5 mL)

NATFLUA/B-6MC 6 X 0.5 mL
EUR 278.4
Description: Please contact Gentaur in order to receive the datasheet of the product.

HCV NS4 recombinant antigen NS4a+b, Biotin

00116-V-B-01mg 0,1 mg
EUR 321
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate.

HCV NS4 recombinant antigen NS4a+b, Biotin

00116-V-B-1000ug 1000 ug
EUR 1539
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate.

Recombinant Hepatitis C HCV NS4 a+b Protein, Biotin, E.coli-100ug

QP12178-B-100ug 100ug
EUR 381.6

Recombinant Hepatitis C HCV NS4 a+b Protein, Biotin, E.coli-1mg

QP12178-B-1mg 1mg
EUR 1873.2

Recombinant Hepatitis C HCV NS4 a+b Protein, Biotin, E.coli-500ug

QP12178-B-500ug 500ug
EUR 1154.4

EPA Method 8260 B Volatile ISTD Mix - 3 pack of 1.5mL ampules

ECS-B-051 1.5ML
EUR 118.56

LEXSY Hygro, Hygromycin B, 5 x 1 ml (100 mg/ml) ** shipped on blue ice - must be shipped via overnight service

M-AB-104L 5 x 1 ml
EUR 259
Description: LEXSY Hygro, Hygromycin B, 5 x 1 ml (100 mg/ml) ** shipped on blue ice - must be shipped via overnight service

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

DLR-Bcl2-b-48T 48T
EUR 591.6
Description: A sandwich quantitative ELISA assay kit for detection of Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

DLR-Bcl2-b-96T 96T
EUR 769.2
Description: A sandwich quantitative ELISA assay kit for detection of Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Bovine Vascular Endothelial Growth Factor B (VEGFB) ELISA Kit

DLR-VEGFB-b-48T 48T
EUR 591.6
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Vascular Endothelial Growth Factor B (VEGFB) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Bovine Vascular Endothelial Growth Factor B (VEGFB) ELISA Kit

DLR-VEGFB-b-96T 96T
EUR 769.2
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Vascular Endothelial Growth Factor B (VEGFB) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

We identify PIK3CA, RHOA, MAPK3, PAFAY1B1, CTNNB1, MYC, PRKCA, ERBB2, and CDC42 as a key gene on the MIR-375 network which is set and estimates the possible function of the MIR-375 in the heart muscle, which consists mainly in regulations on signaling paths that are dependent on on RHO-GTPases. We apply our algorithm to predict Mirna’s function into the python module, which is available at GitHub.

Leave A Comment